Gavreto Prices, Coupons, Copay Cards & Patient Assistance
Gavreto (pralsetinib) is a member of the multikinase inhibitors drug class and is commonly used for Non Small Cell Lung Cancer, and Thyroid Cancer.
The cost for Gavreto 100 mg oral capsule is around $11,745 for a supply of 60 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Gavreto is available as a brand name drug only, a generic version is not yet available. View generic Gavreto availability for more details.
Gavreto prices
Oral Capsule
100 mg
Gavreto oral capsule
from $11,744.75
for 60 capsules
Quantity | Per unit | Price |
---|---|---|
60 | $195.75 | $11,744.75 |
90 | $195.69 | $17,612.34 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Gavreto Coupons, Copay Cards and Rebates
Gavreto offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Gavreto Genentech Oncology Co-pay Assistance Program
Eligible commercially insured patients may pay $0 in out-of-pocket costs for the prescribed product; savings of up to $25,000 per product per calendar year; for additional information contact the program at 855-692-6729.
- Applies to:
- Gavreto
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-692-6729 or Visit website
Gavreto SureStart Program
Eligible commercially insured patients may be eligible to receive a 30-day supply of medication at no cost while awaiting an insurance coverage determination; for additional information contact the program at 877-436-3683.
- Applies to:
- Gavreto
- Number of uses:
- Temporary Assistance
Form more information phone: 877-436-3683 or Visit website
Gavreto Genentech Oncology Co-pay Assistance Program Rebate
Eligible commercially insured patients enrolled in the program may be entitled to a rebate for their out-of-pocket cost if they paid the provider directly for treatment; for additional information contact the program at 855-692-6729.
- Applies to:
- Gavreto
- Number of uses:
- One rebate per prescription fill
Form more information phone: 855-692-6729 or Visit website
Patient Assistance & Copay Programs for Gavreto
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance.Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Gavreto (pralsetinib) Capsule
More information please phone: 866-316-7263 Visit Website
Provider: Rigel OneCare Program: Gavreto
Eligibility requirements:- Contact program for details.
- At or below 500% of FPL
- FDA-approved diagnosis
- Must be a legal resident of the United States or its territories
- Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Gavreto (pralsetinib) Capsule
More information please phone: 833-744-3562 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Gavreto (pralsetinib)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español